2022
DOI: 10.3390/ijms23126381
|View full text |Cite
|
Sign up to set email alerts
|

The Development of FAK Inhibitors: A Five-Year Update

Abstract: Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed in different solid cancers. In recent years, FAK has been recognized as a new target for the development of antitumor agents, useful to contrast tumor development and metastasis formation. To date, studies on the role of FAK and FAK inhibitors are of great interest for both pharmaceutical companies and academia. This review is focused on compounds able to block FAK with different potencies and with different mechanisms of action, that… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(14 citation statements)
references
References 72 publications
0
14
0
Order By: Relevance
“…FAK is a key kinase involved in the formation of cell adhesive plaque. The downregulation of FAK expression can lead to changes in a wide range of signal-regulated proteins that are related to tumor invasion and migration, such as the downregulation of MMP-9 activity in the extracellular matrix, PI3K/Akt/NF-κB signal pathway inhibition, and F-actin depolymerization ( 73 ). In conclusion, the above-mentioned studies reveal that TQ can inhibit several key molecules such as FAK, Akt, NF-κB, and MMP-9 and that these molecules interact in a cascade to affect the metastasis of pancreatic cancer.…”
Section: Discussionmentioning
confidence: 99%
“…FAK is a key kinase involved in the formation of cell adhesive plaque. The downregulation of FAK expression can lead to changes in a wide range of signal-regulated proteins that are related to tumor invasion and migration, such as the downregulation of MMP-9 activity in the extracellular matrix, PI3K/Akt/NF-κB signal pathway inhibition, and F-actin depolymerization ( 73 ). In conclusion, the above-mentioned studies reveal that TQ can inhibit several key molecules such as FAK, Akt, NF-κB, and MMP-9 and that these molecules interact in a cascade to affect the metastasis of pancreatic cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, inhibiting FAK kinase activity has been reported to reduce cancer stem cells and attract regulatory T cells (Tregs), resulting in changes to the tumor immune microenvironment and increasing sensitivity to chemotherapy. 6,7 Several inhibitors, such as Defactinib , 8 VS-4718 , 9 CEP-3744 , 10 and PF-562271 , 11 as shown in Fig. 1, are currently being developed to control cancer growth.…”
Section: Introductionmentioning
confidence: 99%
“…ATP-competitive inhibitors targeting the kinase domain are promising therapeutic interventions for several types of cancers, and many are currently being studied in advanced clinical trials. However, throughout the lead optimization process, there was an uncertain dilemma between selectivity and efficacy, demanding more collaborative efforts using computational modeling and medicinal chemistry [ 6 ].…”
Section: Introductionmentioning
confidence: 99%